Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$63.74 USD
+1.37 (2.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $63.73 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.74 USD
+1.37 (2.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $63.73 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Zacks News
Why Edwards Lifesciences (EW) Isn't Done Growing Earnings Yet
by Zacks Equity Research
Edwards Lifesciences (EW) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Regeneron, Edwards Lifesciences, Alexion Pharmaceuticals, Align Technology and Centene
5 Healthcare Innovators I'm Still Buying
by Kevin Cook
When you think long-term about the megatrends in healthcare, it makes picking winners easier
Edwards Lifesciences (EW) Tops Q1 Earnings, Updates '17 View
by Zacks Equity Research
Edwards Lifesciences Corp. (EW) reported first-quarter 2017 adjusted earnings per share (EPS) of 94 cents, which surpassed the Zacks Consensus Estimate by 14.6%.
Medical Product Stocks Earnings on Apr 25: SYK, EW, LH
by Zacks Equity Research
Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.
Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store?
by Zacks Equity Research
Edward Lifesciences Corp. (EW) is scheduled to report first-quarter 2017 earnings results after market close on Apr 25.
Should You Make a Bet on the Healthcare Stocks?
by Tracey Ryniec
The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.
Why Is Edwards (EW) Up 4.1% Since the Last Earnings Report?
by Zacks Equity Research
Edwards (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Biggest Winners from the Obamacare Replacement Bill Pushback
by Swarup Gupta
This setback was largely an outcome of the lack of consensus among various factions of the GOP.
Edwards Lifesciences (EW) Beats on Earnings & Sales in Q4
by Zacks Equity Research
Edwards Lifesciences Corp. (EW) reported fourth-quarter 2016 adjusted earnings per share (EPS) of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%.
Edward Lifesciences (EW): What's in Store in Q4 Earnings?
by Zacks Equity Research
Edward Lifesciences Corp. (EW) is scheduled to report fourth-quarter and full-year 2016 earnings results after market close on Feb 1, 2017.
The Clouds Will Lift After the Vote
by Sheraz Mian
The tightening of polls in recent days has added to uncertainty, but we will see a collective sigh of relief after a clear verdict.
Analyst Reports for Sprint, Eli Lilly, & United Technologies
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), Sprint (S) and Eli Lilly (LLY).
4 Med Instrument Stocks for Q3 Earnings amid Election Chaos
by Zacks Equity Research
The medical device sector is positioned for impressive growth in the near term.
The Uncertainty of a Close Election
by Sheraz Mian
The uncertainty of the tight election notwithstanding, stocks will rejoice as the results come in, irrespective of who the winner is.
Bull of the Day: Edwards Lifesciences (EW)
by Kevin Cook
Heart patients and investors around the world are grateful for this valve replacement technology
MedTech Industry Stock Outlook - July 2016
by Zacks Equity Research
Two full quarters of 2016 are behind us and, while we await second quarter results over the coming weeks, we hardly expect a change in trend in the bullish MedTech sector.
Bull of the Day: Edwards Lifesciences (EW)
by Kevin Cook
EW wins as more physicians are choosing minimally invasive heart procedures for their patients
4 Stocks to Buy on Pullbacks
by Jeremy Mullin
The next market pullback will create opportunities to enter performing stocks.